MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Corticosteroids with Anti-infectives (eye)

Drug Safety update

May 2024: Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions

 August 2017: Corticosteroids: rare risk of central serious chorioretinopathy with local as well as systemic use.

Use of combination products is rarely justified except after ocular surgery to reduce inflammation and prevent infections.